Actualidad

/
/
One of the World’s Leading Centers for Cardiovascular Medicine & Transplantation Adopts Masimo’s SedLine® Brain Function Monitoring and O3™ Regional Oximetry

One of the World’s Leading Centers for Cardiovascular Medicine & Transplantation Adopts Masimo’s SedLine® Brain Function Monitoring and O3™ Regional Oximetry

07/07/2016

NEUCHÂTEL, Switzerland–(BUSINESS WIRE)–Jul. 7, 2016–
Masimo (NASDAQ:
MASI) announced today that Deutsches Herzzentrum Berlin (DHZB / German
Heart Center Berlin) in Berlin, Germany, has adopted Masimo’s SedLine®
Brain Function Monitoring and O3™ Regional Oximetry technologies to
monitor patients in the operating room and intensive care unit.

This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20160707005661/en/

“Our non-profit hospital performs over 32,000 treatments each year. Easy
access to advanced parameters and the data they provide are very
important for ou…

Más información: One of the World’s Leading Centers for Cardiovascular Medicine & Transplantation Adopts Masimo’s SedLine® Brain Function Monitoring and O3™ Regional Oximetry

Comparte:

El contenido de este sitio web está destinado únicamente a profesionales médicos/sanitarios.

Es posible que los productos contenidos en este sitio no estén disponibles en todos los mercados, ya que la disponibilidad está sujeta a prácticas normativas y médicas en mercados individuales.